ArticleScientific reports2025
Abnormality detection in nailfold capillary images using deep learning with EfficientNet and cascade transfer learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Enhancing nail disease diagnosis: a capsule network with SE attention and dual backbone models.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Artificial Intelligence Meets Nail Diagnostics: Emerging Image-Based Sensing Platforms for Non-Invasive Disease Detection.Bioengineering (Basel, Switzerland) · 2026Review
- Nailfold capillaroscopy in diabetic retinopathy: microvascular insights, clinical value, and translational challenges - a narrative review.Frontiers in endocrinology · 2026Review
- Deep Learning Performance in Analyzing Nailfold Videocapillaroscopy Images in Systemic Sclerosis.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nailfold Capillaroscopy (NFC) is a simple, non-invasive diagnostic tool used to detect microvascular changes in nailfold. Chronic pathological changes associated with a wide range of systemic diseases, such as diabetes, cardiovascular disorders, and rheumatological conditions like systemic sclerosis, can manifest as observable microvascular changes in the terminal capillaries of nailfolds. The current gold standard relies on experts performing manual evaluations, which is an exhaustive time-intensive, and subjective process. In this study, we demonstrate the viability of a deep learning approach as an automated clinical screening tool. Our dataset consists of NFC images from a total of 225 participants, with normal images accounting for 6% of the dataset. This study introduces a robust framework utilizing cascade transfer learning based on EfficientNet-B0 to differentiate between normal and abnormal cases within NFC images. The results demonstrate that pre-trained EfficientNet-B0 on the ImageNet dataset, followed by transfer learning from domain-specific classes, significantly enhances the classifier's performance in distinguishing between Normal and Abnormal classes. Our proposed model achieved superior performance, with accuracy, precision, recall, F1 score, and ROC_AUC of 1.00, significantly outperforming both models of single transfer learning on the pre-trained EfficientNet-B0 and cascade transfer learning on a convolutional neural network, which each attained an accuracy, precision, recall, and F1 score of 0.67 and a ROC_AUC of 0.83. The framework demonstrates the potential to facilitate early preventive measures and timely interventions that aim to improve healthcare delivery and patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.